Sun Pharma Advanced Research Company Limited (SPARC.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 37.29B |
| Enterprise Value | 42.87B |
| P/E Ratio | 5.01 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 4.14 |
| Price/Book Ratio | 5.81 |
| Enterprise/Revenue | 4.44 |
| Enterprise/EBITDA | 5.22 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.83 |
| Operating Margin | 0.85 |
AD
Management Effectiveness
| Return On Assets | 0.72 |
| Return On Equity | 11.09 |
Income Statement
| Revenue | 18.79B |
| Revenue/Share | 57.9 |
| Gross Profit | 17.27B |
| EBITDA | 15.99B |
| Net Income | 15.53B |
| Diluted EPS | 47.86 |
Balance Sheet
| Total Cash | 26.2M |
| Total Cash/Share | 0.08 |
| Total Debt | 5.59B |
| Total Debt/Equity | 0.42 |
| Current Ratio | 2.47 |
| Book Value Per Share | 41.25 |
Price History
| 52-Week Change | 53 |
| 52-Week High | 253.17 |
| 52-Week Low | 108 |
| Moving Average 50 Days | 182.02 |
| Moving Average 200 Days | 144.72 |
Statistics
| Average Volume | 6.51M |
| Shares Outstanding | 324.52M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 127:125 |
| Last Split Date | August 23, 2012 |
AD
